This social co-creation project aims to improve public understanding of drug development and create an environment where people can more easily access and engage with clinical trials. Through collaboration among industry, researchers, healthcare professionals, patient organizations, and members of the public, the project develops and supports Clinical Trial Ambassadors who help promote awareness and understanding of clinical research. The project represents an open innovation approach to Patient and Public Involvement (PPI) in medicines development, bringing together diverse stakeholders to learn, collaborate, and take action.

​

The core program of the project, the Clinical Trial Ambassador Training Program, is open to anyone interested in learning more about drug development and clinical trials. Since 2025, participants have included not only patients, family members, patient advocates, and representatives of patient organizations, but also healthcare professionals, researchers, and industry representatives. The program has become a unique space for learning and dialogue across different perspectives and backgrounds. Graduates of the training program, known as Clinical Trial Ambassadors, also contribute as lecturers and tutors, helping to support and inspire new participants.